Imugene Limited
Imugene Limited (IUGNF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IUGNF · as of Jun 9, 2026
Key Statistics
Explore Imugene Limited Data
iugnf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
iugnf competitorsIUGNF
BSEM
CLTEF
HSCHF
KNTPF
MSCLFStock Performance
Full HistoryAbout Imugene Limited
Imugene Limited an Australian firm specializing in clinical-stage immuno-oncology, is dedicated to conceiving diverse immunotherapies. Its core mission involves activating the immune systems of cance…
what is imugene limited · iugnf stock overview · imugene limited company profile · who is imugene limited ceo · iugnf OTC · imugene limited headquarters · imugene limited business segments
About Stock Overview & Key Data
Imugene Limited (IUGNF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jul 5, 2019. As of the latest trading session, IUGNF stock price is $0.10, with a market capitalization of $43.5M. The stock has returned -74.17% over the past 12 months and -59.81% year-to-date.
In fiscal year 2025, Imugene Limited reported revenue of $4.4M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Imugene Limited (IUGNF) stock price is $0.10. The stock is traded on OTC under the ticker symbol IUGNF. The 52-week range is $0.06 – $0.65.